{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:49:41Z","timestamp":1788871781272,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.neurobiolaging.2021.10.017","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T12:23:49Z","timestamp":1635769429000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Cerebrospinal fluid dynamics and discordant amyloid biomarkers"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-0691","authenticated-orcid":false,"given":"Jonathan","family":"Graff-Radford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Wiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-4476","authenticated-orcid":false,"given":"Petrice M.","family":"Cogswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argonde","family":"Van Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-1185","authenticated-orcid":false,"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill R.","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0001","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","article-title":"CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus","volume":"116","author":"Agren-Wilsson","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.media.2007.06.004","article-title":"Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain","volume":"12","author":"Avants","year":"2008","journal-title":"Med Image Anal"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0003","doi-asserted-by":"crossref","first-page":"e12190","DOI":"10.1002\/dad2.12190","article-title":"P-tau\/Abeta42 and Abeta42\/40 ratios in CSF are equally predictive of amyloid PET status","volume":"13","author":"Campbell","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0004","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/NEN.0000000000000191","article-title":"Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus","volume":"74","author":"Elobeid","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0005","doi-asserted-by":"crossref","first-page":"e2237","DOI":"10.1212\/WNL.0000000000008616","article-title":"Cerebrospinal fluid dynamics disorders: relationship to Alzheimer biomarkers and cognition","volume":"93","author":"Graff-Radford","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0006","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.0000000000000916","article-title":"Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2018.11.015","article-title":"Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods","volume":"21","author":"Gunter","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1743-8454-7-18","article-title":"Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study","volume":"7","author":"Hashimoto","year":"2010","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2176\/nmc.48.197","article-title":"Prevalence of idiopathic normal-pressure hydrocephalus in the elderly population of a Japanese rural community","volume":"48","author":"Hiraoka","year":"2008","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0011","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0012","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0013","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer's disease","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0014","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000000342","article-title":"Prevalence of idiopathic normal-pressure hydrocephalus","volume":"82","author":"Jaraj","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0015","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0017","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","article-title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease","volume":"78","author":"Knopman","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0018","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/brain\/aww160","article-title":"Pittsburgh compound B imaging and cerebrospinal fluid amyloid-\u03b2 in a multicentre European memory clinic study","volume":"139","author":"Leuzy","year":"2016","journal-title":"Brain: a journal of neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0019","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awu367","article-title":"Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer's disease","volume":"138","author":"Mattsson","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-170327","article-title":"The cerebrospinal fluid A\u03b21-42\/A\u03b21-40 ratio improves concordance with amyloid-PET for diagnosing alzheimer's disease in a clinical setting","volume":"60","author":"Niemantsverdriet","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0021","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/brain\/aww015","article-title":"Cerebrospinal fluid analysis detects cerebral amyloid-\u03b2 accumulation earlier than positron emission tomography","volume":"139","author":"Palmqvist","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0022","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-017-01150-x","article-title":"Earliest accumulation of \u03b2-amyloid occurs within the default-mode network and concurrently affects brain connectivity","volume":"8","author":"Palmqvist","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0023","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010739","article-title":"Association of amyloid-\u03b2 CSF\/PET discordance and tau load five years later","author":"Reimand","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13195-019-0561-5","article-title":"PET and CSF amyloid-\u03b2 status are differently predicted by patient features: information from discordant cases","volume":"11","author":"Reimand","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0026","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0027","first-page":"P93","article-title":"The mayo clinic adult life span template: better quantification across the life span","volume":"13","author":"Schwarz","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0028","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester epidemiology project (REP) medical records-linkage system","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0029","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1212\/WNL.0000000000009874","article-title":"CSF biomarkers in olmsted county: Evidence of 2 subclasses and associations with demographics","volume":"95","author":"Van Harten","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.24719","article-title":"Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease","volume":"80","author":"Vlassenko","year":"2016","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.025","article-title":"NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers","volume":"44","author":"Vos","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.10.017_bib0032","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","article-title":"Amyloid beta peptide ratio 42\/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load","volume":"101","author":"Wiltfang","year":"2007","journal-title":"J Neurochem"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021003298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021003298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:38:42Z","timestamp":1759318722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021003298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":32,"alternative-id":["S0197458021003298"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.10.017","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid dynamics and discordant amyloid biomarkers","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}